Invention gives improved gene technology analysis

Apr 24, 2008

A patent for a system that gives more reliable results in gene technology-based diagnostic tests has been granted to researchers at the Norwegian Institute of Public Health (NIPH).

Gene technology analysis is used increasingly in diagnostic tests for detection of minute amounts of cells, bacteria and viruses in biological samples. However, false positive or negative results may occur.

- To uncover false negative results, an internal control reagent can be included in the tests to verify that the analysis results are valid. The problem with the internal controls used in today’s analyses is that they can only be added during, or at the end of the analysis process. This means that quality assurance is incomplete, explains Einar Sverre Berg at the Department for Virology.

Together with colleague Kjell Skaug he invented a protective shell for the internal control, based on cell/virus-mimicking liposomes. The liposome/internal control particles can thus be mixed with the biological test material when the sample is taken and be present during the entire analytical process. Whole process quality assurance is thereby achieved with more reliable results.

Chlamydia test first

Berg and Skaug were among the first in the world to show that restrictive substances in urine samples are an important source of false negative results in gene technology-based chlamydia tests.

The scientists recognised the problem with incomplete quality assurance, and invented the solution for the tests.

- A fantastic property of the system is that it isn’t limited to just one test. It can be used in any gene technology-based assay detecting biologically substances. The liposome can be tailored and adapted according to the target – be it a virus or bacterium. The potential, in other words, is enormous, says Berg.

Berg and his colleague have applied for a patent on their discovery in all industrialised countries and have established the company IC Particles AS. Patents were first granted in New Zealand and Australia, followed by Norway. Berg is also optimistic about getting a patent in the USA within this year.

- Without the NIPH’s goodwill and patience it is likely that the IC Particle’s invention would not have been developed, concludes Einar Sverre Berg.

Source: Norwegian Institute of Public Health

Explore further: GMO mosquito plan sparks outcry in Florida

add to favorites email to friend print save as pdf

Related Stories

GMO mosquito plan sparks outcry in Florida

21 hours ago

A British company's plan to unleash hordes of genetically modified mosquitoes in Florida to reduce the threat of dengue fever and other diseases has sparked an outcry from fearful residents.

Population genomics unveil seahorse domain

Jan 30, 2015

In a finding vital to effective species management, a team including City College of New York biologists has determined that the lined seahorse (Hippocampus erectus) is more a permanent resident of the we ...

Picking up on the smell of evolution

Jan 28, 2015

UA researchers have discovered some of the changes in genes, physiology and behavior that enable a species to drastically change its lifestyle in the course of evolution.

Supercomputing the evolution of a model flower

Jan 27, 2015

Scientists using supercomputers found genes sensitive to cold and drought in a plant help it survive climate change. These findings increase basic understanding of plant adaptation and can be applied to improve ...

Recommended for you

GMO mosquito plan sparks outcry in Florida

21 hours ago

A British company's plan to unleash hordes of genetically modified mosquitoes in Florida to reduce the threat of dengue fever and other diseases has sparked an outcry from fearful residents.

Population genomics unveil seahorse domain

Jan 30, 2015

In a finding vital to effective species management, a team including City College of New York biologists has determined that the lined seahorse (Hippocampus erectus) is more a permanent resident of the we ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.